According to Marksans Pharma 's latest financial reports the company's current EPS (TTM) is $0.11. In 2022 the company made an earnings per share (EPS) of $0.09258 a decrease over its 2021 EPS that were of $0.11.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $0.11 | 14.96% |
2022 | $0.09258 | -17.15% |
2021 | $0.11 | 18.87% |
2020 | $0.09400 | 124.41% |
2019 | $0.04189 | 39.85% |
2018 | $0.02995 | 65.56% |
2017 | $0.01809 | 279.37% |
2016 | $0.004768 | -91.46% |
2015 | $0.05585 | -2.27% |
2014 | $0.05714 | -11.5% |
2013 | $0.06457 |